ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Cardiovascular"

  • Abstract Number: 0604 • ACR Convergence 2025

    Assessment of the Metabolic Score for Insulin Resistance (METS-IR) and Its Associated Factors in Patients with Systemic Lupus Erythematosus

    Antonio Aznar-Esquivel1, Fuensanta Gómez-Bernal1, María García-González2, Marta Hernández Díaz1, Juan C. Quevedo-Abeledo3, Miguel A. González-Gay4 and Iván Ferraz Amaro1, 1Servicio Canario de Salud, La Laguna, Canarias, Spain, 2Servicio Canario de Salud, La Laguna, Spain, 3Hospital Doctor Negrín, Las Palmas de Gran Canaria, Canarias, Spain, 4Department of Rheumatology and Joint and Bone Research Unit, Hospital Universitario Fundación Jiménez Díaz, and Instituto de Investigación Sanitaria-Fundación Jiménez Díaz, Madrid, Spain, and Medicine and Psychiatry Department, University of Cantabria, Santander, Spain

    Background/Purpose: The Metabolic Score for Insulin Resistance (METS-IR) is a recently developed index proposed as a predictor of cardiovascular (CV) events. In this study, we…
  • Abstract Number: 0435 • ACR Convergence 2025

    Comparative Outcomes in Seropositive and Seronegative Rheumatoid Arthritis: A Retrospective Cohort Study

    Ahmad Alomari1, Reem Elmusa2, Nikita Shah3, Miguel Rodriguez4 and Diala Alawneh5, 1UCF- North Florida hospital, Gainesville, FL, 2UCF/ HCA - North florida hospital, Gainesville, FL, 3UCF/HCA Florida North Florida Hospital, Gainesville, FL, 4SIMED Rheumatology, Gainesville, FL, 5University of Florida, Gainesville, FL

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic autoimmune disease that manifests as either seropositive or seronegative subtypes. Seropositive RA, characterized by the presence of autoantibodies…
  • Abstract Number: 2470 • ACR Convergence 2025

    Impaired Myocardial Flow Reserve on 82-Rubidium Positron Emission Tomography in Patients with Systemic Sclerosis

    Attila Feher1, Morgan Emokpae2, Bindu Koyi2, Ibolya Csecs2, Baran Gunes3, Albert Sinusas2 and Monique Hinchcliff4, 1Yale University School of Medicine - New Haven, CT, New Haven, CT, 2Yale School of Medicine, New Haven, 3Yale University School of Medicine, Pompton Plains, NJ, 4Yale School of Medicine, Westport, CT

    Background/Purpose: Cardiovascular death ranks as the second leading cause of mortality related to systemic sclerosis (SSc), with coronary microvascular dysfunction (CMVD) likely contributing to this…
  • Abstract Number: 1993 • ACR Convergence 2025

    Risk of Cardiovascular Conditions, Bone Fractures and Mortality in Patients with Uncontrolled Gout in Comparison to Those with Controlled Gout

    Tingting Zhang1, Christian W. Mende2, Ashraf El-Meanawy3, Michael Pillinger4, Kaiding Zhu5, Bradley Marder6 and Brian Lamoreaux7, 1Amgen, Inc., Thousand Oaks, 2University of California San Diego, San Diego, CA, 3Medical College of Wisconsin, Milwaukee, WI, 4New York University Grossman School of Medicine, New York,, NY, 5Amgen, Inc., San Francisco, CA, 6AMGEN, Inc, Denver, CO, 7Amgen, Inc., Deerfield, IL

    Background/Purpose: Gout may increase the risk of cardiovascular events (CVEs) and bone fractures through urate deposition and chronic inflammation1,2. However, the additional effects of uncontrolled…
  • Abstract Number: 1623 • ACR Convergence 2025

    The Association of Calprotectin with Vascular Injury and Remodeling in Clinically-Isolated Aortitis

    Katarina Kmetova1, Gavin Poppei2, Kavya Sugur3, Julia Ford4, Wenying Liang4, Emily Chong4, Srilakshmi Yalavarthi4, NaveenKumar Somanathapura4, Nataliya Milman5, Peter Merkel6, Ora Singer7 and Yu (Ray) Zuo4, 1Division of Rheumatology, University of Michigan, Ann Arbor, Michigan, USA, Ann Arbor, MI, 2University of Michigan, Ann arbor, 3Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Ann Arbor, MI, 4University of Michigan, Ann Arbor, MI, 5the Ottawa Hospital, Ottawa, ON, Canada, 6University of Pennsylvania, Philadelphia, PA, 7University of Michigan, Huntington Woods, MI

    Background/Purpose: Clinically-isolated aortitis (CIA), defined as inflammation of the aortic wall in the absence of extra-aortic arterial involvement, systemic vasculitis, or other associated autoimmune disease,…
  • Abstract Number: 1182 • ACR Convergence 2025

    Cardiac Sarcoidosis in Black Patients: A Biopsy-Confirmed Cohort Study

    Roshan Subedi1, Haya Haddad2, Rachel Barish1, Tania Vora1, Nana Afari-Armah3, Ajay Kadakkal1, Farooq Sheikh1 and Florina Constantinescu1, 1Medstar Washington Hospital Center, Washington, DC, 2Medstar Washington Hospital Center, Silver Spring, MD, 3Medstar Washington Hospital Center, Washington

    Background/Purpose: Sarcoidosis is an inflammatory disease characterized by non-necrotizing granulomatous inflammation that can affect any organ. Approximately 5% of patients with sarcoidosis develop clinically significant…
  • Abstract Number: 0599 • ACR Convergence 2025

    Efficacy of Statin Medications for Secondary Prevention of Atherosclerotic Cardiovascular Disease Among Patients with Systemic Lupus Erythematosus

    Aakash V. Patel1, Lingxiao Zhang2, Emily S. Lau3, Baijun Zhou2, Yuqing Zhang4, Hyon K. Choi5 and April Jorge6, 1Massachusetts General Hospital, Harvard Medical School, Boston, MA, 2Massachusetts General Hospital, Boston, 3Massachusetts General Hospital, Harvard Medical School, Boston, 4Massachusetts General Hospital, Quincy, MA, 5MASSACHUSETTS GENERAL HOSPITAL, Lexington, MA, 6Massachusetts General Hospital, Boston, MA

    Background/Purpose: Systemic lupus erythematosus (SLE) is associated with up to a three-fold increased risk of myocardial infarction (MI) and stroke. Statins have well-established cardioprotective benefits…
  • Abstract Number: 0346 • ACR Convergence 2025

    Fibroblast Growth Factor-23 and Bone Status in Patients with Chronic Kidney Disease Compared to a Healthy Control Group and Its Relationship with Cardiovascular Risk

    José Rodríguez gago1, Carolina Tornero2, Lina León3, María Luisa González-Casaus3, Luisa Fernanda Giraldo3, Gloria del Peso3, Diego Garrido3, Teresa López3, Mónica Coronado3, María Auxiliadora Bajo4, Sara García3, María Gema Serrano3, Marta Ossorio3, Alejandro Balsa3 and Pilar Aguado3, 1Hospital Universitario La Paz, MADRID, 2Hospital La Paz, Madrid, Spain, 3Hospital Universitario La Paz, Madrid, Spain, 4Hospital Universitario de la Princesa - ISS Princesa, Madrid, Spain

    Background/Purpose: Chronic kidney disease (CKD) is linked to increased vascular comorbidity and fracture risk. This study aims to assess bone status in CKD patients versus…
  • Abstract Number: 2438 • ACR Convergence 2025

    SGLT2 Inhibitors in SLE: Impact on Pulmonary Hypertension, Mortality, and Renal Outcomes

    Ahmad Alomari1, Asim Khanfar2, Miguel Rodriguez3 and Diala Alawneh4, 1UCF- North Florida hospital, Gainesville, FL, 2Rochester General Hospital, Rochester, NY, 3SIMED Rheumatology, Gainesville, FL, 4University of Florida, Gainesville, FL

    Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease linked to significant morbidity, including pulmonary hypertension (PH). While SGLT2 inhibitors are known for cardiovascular…
  • Abstract Number: 1984 • ACR Convergence 2025

    Improving Lipid Screening Rates in Rheumatic Disease Patients: An Academic Fellowship Quality Improvement Project

    Mahnoor Javed1, Deepak Jagannath2, Lilly Morgan1, Rishi Patel1, Eleonora Avenatti1, Kanika Monga1 and Kenneth Williams1, 1Houston Methodist, Houston, 2Houston Methodist Hospital, Sugar Land, TX

    Background/Purpose: Autoimmune diseases, including rheumatoid arthritis (RA) and spondyloarthritis (SpA)—which encompasses ankylosing spondylitis (AS) and psoriatic arthritis (PsA)—are associated with chronic inflammation and increased cardiovascular…
  • Abstract Number: 1553 • ACR Convergence 2025

    Circulating Monocyte Level Is Associated With Pulmonary Vascular Disease and Right Ventricular Dysfunction in Systemic Sclerosis

    Ai Yaku1, Bong Joon Kim2, Hidenori Yaku1, Carrie Richardson2, Michael Cuttica2, Ruben Mylvaganam2, Vera Rigolin2, Matthew Feinstein2 and Sanjiv Shah1, 1Northwestern University, Chicago, IL, 2Northwestern University, Chicago

    Background/Purpose: Pulmonary arterial hypertension associated with systemic sclerosis (SSc-PAH) is a life-threatening condition with obliterative pulmonary vascular remodeling, right ventricular (RV) dysfunction, and poor prognosis.…
  • Abstract Number: 1137 • ACR Convergence 2025

    Increased Risk of Cardiovascular Events and Mortality Related to Diffuse Idiopathic Skeletal Hyperostosis (DISH): A Systematic Review and Meta-Analysis

    Pitchaporn Yingchoncharoen1, Nattanicha Chaisrimaneepan2, Miriam Paz3, Chanokporn Puchongmart1, Ben thiravetyan1, Panat Yanpiset1 and Jerapas Thongpiya4, 1Texas Tech Health Sciences Center, Lubbock, TX, 2Department of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, 3Texas Tech University Health Sciences Center, Lubbock, 4Texas Tech University Health Sciences Center at Lubbock Program, Lubbock, TX

    Background/Purpose: Diffuse Idiopathic Skeletal Hyperostosis (DISH) is characterized by ossification and calcification of the entheses with prevalence increasing with age. It has been reported to…
  • Abstract Number: 0598 • ACR Convergence 2025

    Study of Long Term HCQ Safety on Cardiac Muscle Function in Patients with SLE and other Rheumatic Diseases

    Jaspreet Bhatti1, Kyu-In Lee2, Nirali Sanghavi3, Stephen Zak4, Julia Ash5, James Miceli6, Kirk Sperber4, Stephen Pan7 and Amy Wasserman8, 1Westchester Medical Center, Hopewell Junction, NY, 2Westchester Medical Center, Fort Lee, NJ, 3Westchester Medical Center, White Plains, NY, 4New York Medical College, Valhalla, 5Westchester Medical center, Dobbs Ferry, NY, 6Westchester Medical Center, Hawthorne, NY, 7Westchester Medical Center, Valhalla, 8New York Medical College at Westchester Medical Center, Armonk, NY

    Background/Purpose: HCQ induced cardiomyopathy leading to heart failure is a rare but serious potential treatment complication. Currently there are no screening guidelines for detecting HCQ…
  • Abstract Number: 0315 • ACR Convergence 2025

    Cross-sectional analysis of association between erosive hand osteoarthritis and cardiovascular disease.

    Avanika Mahajan1, Caroyln Harvey2, Andy Abril3 and Megan Sullivan4, 1Mayo Clinic, Scottsdale, 2Mayo Clinic, Phoenix, AZ, 3Mayo Clinic Florida, Jacksonville, 4Mayo Clinic Arizona, Scottsdale, AZ

    Background/Purpose: Erosive hand osteoarthritis (EHOA) is an inflammatory subtype of hand OA that causes subchondral bone erosion and cortical destruction, often resulting in debilitating symptoms.…
  • Abstract Number: 0205 • ACR Convergence 2024

    Cardiovascular Event Risks Among Members with Rheumatoid Arthritis, Psoriatic Arthritis, and Systemic Lupus Erythematosus

    Jean Park1, Cliff Rutter2, Elisea Avalos-Reyes3, Mary Anderson4, Will Cavers5, Dorothea Verbrugge6 and Kjel Johnson7, 1CVS Health, Hartford, CT, 2CVS Health, Fair Oaks Ranch, TX, 3CVS Health, Highland Village, TX, 4CVS Health, Irving, TX, 5CVS Health, Palm Beach Gardens, 6CVS Health, Salt Lake City, 7CVS Health, Tampa

    Background/Purpose: A growing body of evidence highlights a link between rheumatic diseases such as rheumatoid arthritis (RA), psoriatic arthritis (PA), and systemic lupus erythematosus (SLE)…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 38
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology